fluoxetine has been researched along with transforming growth factor beta in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, YK; Lee, KM | 1 |
| Arumugasaamy, N; Fisher, JP; Gudelsky, A; Hurley-Novatny, A; Kim, PCW | 1 |
1 trial(s) available for fluoxetine and transforming growth factor beta
| Article | Year |
|---|---|
The role of IL-12 and TGF-beta1 in the pathophysiology of major depressive disorder.
Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder, Major; Female; Fluoxetine; Humans; Interleukin-12; Male; Middle Aged; Paroxetine; Time Factors; Transforming Growth Factor beta; Transforming Growth Factor beta1; Treatment Outcome; Venlafaxine Hydrochloride | 2006 |
1 other study(ies) available for fluoxetine and transforming growth factor beta
| Article | Year |
|---|---|
Model Placental Barrier Phenotypic Response to Fluoxetine and Sertraline: A Comparative Study.
Topics: Cell Membrane Permeability; Extracellular Matrix; Female; Fluoxetine; Human Umbilical Vein Endothelial Cells; Humans; Models, Biological; Phenotype; Placenta; Pregnancy; Selective Serotonin Reuptake Inhibitors; Sertraline; Transforming Growth Factor beta; Trophoblasts | 2019 |